Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity

Delwin J. Long, Karim Iskander, Amos Gaikwad, Meral Arin, Dennis R. Roop, Richard Knox, Roberto Barrios, Anil K. Jaiswal

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry